Causaly plans to use the new funding to extend its product lead and expand its commercial relationships. The company’s AI platform is used by 12 of the top 20 pharmaceutical companies, according to a July 13 news release.
The latest funding round brings Causaly’s total raised to $93 million.
“Recent advances in AI open completely new possibilities, and there is a great need for transparent AI systems that science leaders can trust,” Causaly CEO and co-founder Yiannis Kiachopoulos said in the release. “Knowledge is the lifeblood of research organizations, and we are committed to our mission to make it discoverable, working with our customers to make sense of their scientific data and apply insights to enable evidence-driven decisions.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
